These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 24631727)
1. Novel insights on the structural determinants of clozapine and olanzapine multi-target binding profiles. Selent J; Marti-Solano M; Rodríguez J; Atanes P; Brea J; Castro M; Sanz F; Loza MI; Pastor M Eur J Med Chem; 2014 Apr; 77():91-5. PubMed ID: 24631727 [TBL] [Abstract][Full Text] [Related]
2. A QM protein-ligand investigation of antipsychotic drugs with the dopamine D2 Receptor (D2R). Ekhteiari Salmas R; Serhat Is Y; Durdagi S; Stein M; Yurtsever M J Biomol Struct Dyn; 2018 Aug; 36(10):2668-2677. PubMed ID: 28805144 [TBL] [Abstract][Full Text] [Related]
3. The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: comparison with aripiprazole, ziprasidone, bifeprunox and F15063. Assié MB; Carilla-Durand E; Bardin L; Maraval M; Aliaga M; Malfètes N; Barbara M; Newman-Tancredi A Eur J Pharmacol; 2008 Sep; 592(1-3):160-6. PubMed ID: 18640111 [TBL] [Abstract][Full Text] [Related]
4. Design, synthesis and evaluation of benzo[a]thieno[3,2-g]quinolizines as novel l-SPD derivatives possessing dopamine D1, D2 and serotonin 5-HT1A multiple action profiles. Li Z; Huang J; Sun H; Zhou S; Guo L; Zhou Y; Zhen X; Liu H Bioorg Med Chem; 2014 Nov; 22(21):5838-46. PubMed ID: 25308766 [TBL] [Abstract][Full Text] [Related]
5. Differential profile of antipsychotics at serotonin 5-HT1A and dopamine D2S receptors coupled to extracellular signal-regulated kinase. Bruins Slot LA; De Vries L; Newman-Tancredi A; Cussac D Eur J Pharmacol; 2006 Mar; 534(1-3):63-70. PubMed ID: 16497294 [TBL] [Abstract][Full Text] [Related]
6. Interaction of clozapine and its nitrenium ion with rat D2 dopamine receptors: in vitro binding and computational study. Dilly S; Liégeois JF J Comput Aided Mol Des; 2011 Feb; 25(2):163-9. PubMed ID: 21184252 [TBL] [Abstract][Full Text] [Related]
7. Novel antipsychotics activate recombinant human and native rat serotonin 5-HT1A receptors: affinity, efficacy and potential implications for treatment of schizophrenia. Newman-Tancredi A; Assié MB; Leduc N; Ormière AM; Danty N; Cosi C Int J Neuropsychopharmacol; 2005 Sep; 8(3):341-56. PubMed ID: 15707540 [TBL] [Abstract][Full Text] [Related]
8. Downregulation of 5-HT7 Serotonin Receptors by the Atypical Antipsychotics Clozapine and Olanzapine. Role of Motifs in the C-Terminal Domain and Interaction with GASP-1. Manfra O; Van Craenenbroeck K; Skieterska K; Frimurer T; Schwartz TW; Levy FO; Andressen KW ACS Chem Neurosci; 2015 Jul; 6(7):1206-18. PubMed ID: 25706089 [TBL] [Abstract][Full Text] [Related]
9. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. Kapur S; Zipursky RB; Remington G Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565 [TBL] [Abstract][Full Text] [Related]
10. The clozapine metabolite N-desmethylclozapine displays variable activity in diverse functional assays at human dopamine D₂ and serotonin 5-HT₁A receptors. Heusler P; Bruins Slot L; Tourette A; Tardif S; Cussac D Eur J Pharmacol; 2011 Nov; 669(1-3):51-8. PubMed ID: 21835172 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and dual D2 and 5-HT1A receptor binding affinities of 5-piperidinyl and 5-piperazinyl-1H-benzo[d]imidazol-2(3H)-ones. Ullah N J Enzyme Inhib Med Chem; 2014 Apr; 29(2):281-91. PubMed ID: 23488743 [TBL] [Abstract][Full Text] [Related]
12. The differential actions of clozapine and other antipsychotic drugs on the translocation of dopamine D2 receptors to the cell surface. Schrader JM; Irving CM; Octeau JC; Christian JA; Aballo TJ; Kareemo DJ; Conti J; Camberg JL; Lane JR; Javitch JA; Kovoor A J Biol Chem; 2019 Apr; 294(14):5604-5615. PubMed ID: 30670597 [TBL] [Abstract][Full Text] [Related]
13. Clozapine derived 2,3-dihydro-1H-1,4- and 1,5-benzodiazepines with D4 receptor selectivity: synthesis and biological testing. Hussenether T; Hübner H; Gmeiner P; Troschütz R Bioorg Med Chem; 2004 May; 12(10):2625-37. PubMed ID: 15110844 [TBL] [Abstract][Full Text] [Related]
14. The effect of zotepine, risperidone, clozapine and olanzapine on MK-801-disrupted sensorimotor gating. Bubeníková V; Votava M; Horácek J; Pálenícek T; Dockery C Pharmacol Biochem Behav; 2005 Apr; 80(4):591-6. PubMed ID: 15820528 [TBL] [Abstract][Full Text] [Related]
15. New arylpiperazinylalkyl derivatives of 8-alkoxy-purine-2,6-dione and dihydro[1,3]oxazolo[2,3-f]purinedione targeting the serotonin 5-HT1A /5-HT2A /5-HT7 and dopamine D2 receptors. Chłoń-Rzepa G; Zagórska A; Bucki A; Kołaczkowski M; Pawłowski M; Satała G; Bojarski AJ; Partyka A; Wesołowska A; Pękala E; Słoczyńska K Arch Pharm (Weinheim); 2015 Apr; 348(4):242-53. PubMed ID: 25773907 [TBL] [Abstract][Full Text] [Related]
16. No evidence for binding of clozapine, olanzapine and/or haloperidol to selected receptors involved in body weight regulation. Theisen FM; Haberhausen M; Firnges MA; Gregory P; Reinders JH; Remschmidt H; Hebebrand J; Antel J Pharmacogenomics J; 2007 Aug; 7(4):275-81. PubMed ID: 16983399 [TBL] [Abstract][Full Text] [Related]
17. Modeling and protein engineering studies of active and inactive states of human dopamine D2 receptor (D2R) and investigation of drug/receptor interactions. Salmas RE; Yurtsever M; Stein M; Durdagi S Mol Divers; 2015 May; 19(2):321-32. PubMed ID: 25652238 [TBL] [Abstract][Full Text] [Related]
18. Clozapine, a fast-off-D2 antipsychotic. Seeman P ACS Chem Neurosci; 2014 Jan; 5(1):24-9. PubMed ID: 24219174 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and pharmacological evaluation of 11-(1,6-dimethyl-1,2,3,6-tetrahydropyridin-4-yl)-5H-dibenzo[b,e][1,4]diazepines with clozapine-like receptor occupancy at dopamine D Watanabe H; Ishida K; Yamamoto M; Horiguchi M; Isobe Y Bioorg Med Chem Lett; 2020 Nov; 30(21):127563. PubMed ID: 32976928 [TBL] [Abstract][Full Text] [Related]
20. Using pharmacokinetic-pharmacodynamic modelling as a tool for prediction of therapeutic effective plasma levels of antipsychotics. Olsen CK; Brennum LT; Kreilgaard M Eur J Pharmacol; 2008 Apr; 584(2-3):318-27. PubMed ID: 18325493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]